Table 3. HER2 receptor status of primary tumors and solid and effusion metastases of patients analyzed in this study.
IHC | Primary N= 69 |
Solid metastasis N= 15 |
FISH | Primary N= 66 |
Solid metastasis N= 15 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | + | p | - | + | p | - | + | p | - | + | p | ||||||
HER2 | Solid metastasis N = 15 |
- | 12 | 0 | 1 | HER2 | Solid metastasis N=15 |
- | 13 | 0 | 1 | ||||||
+ | 1 | 2 | + | 0 | 2 | ||||||||||||
Effusion N = 69 |
- | 53 | 3 | 0.73 | 11 | 1 | 1 | Effusion N=66 |
- | 56 | 2 | 1 | 13 | 0 | 1 | ||
+ | 5 | 8 | 1 | 2 | + | 2 | 6 | 0 | 2 |
Data are shown for immunohistochemistry and FISH.